Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1824-7288
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone ; volume:38 ; number:1 ; day:31 ; month:10 ; year:2012 ; pages:1-5 ; date:12.2012
The Italian journal of pediatrics ; 38, Heft 1 (31.10.2012), 1-5, 12.2012
- Urheber
-
Tolone, Salvatore
- Beteiligte Personen und Organisationen
-
Pellino, Valeria
Vitaliti, Giovanna
Lanzafame, Angela
Tolone, Carlo
SpringerLink (Online service)
- DOI
-
10.1186/1824-7288-38-63
- URN
-
urn:nbn:de:1111-2016032342512
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tolone, Salvatore
- Pellino, Valeria
- Vitaliti, Giovanna
- Lanzafame, Angela
- Tolone, Carlo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
The impacts of probiotics in eradication therapy of Helicobacter pylori
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study
Drug and therapy development for triple negative breast cancer
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
The impacts of probiotics in eradication therapy of Helicobacter pylori
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study
Drug and therapy development for triple negative breast cancer
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
The impacts of probiotics in eradication therapy of Helicobacter pylori
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy
A comparison between conventional triple therapy and sequential therapy on tolerance of treatment and eradication of Helicobacter pylori infection in Egyptian patients
New Vaccine Therapy for Triple-Negative Breast Cancer
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study
Drug and therapy development for triple negative breast cancer